| |
|
Glantreo News
Winter 2008
 |
Glantreo receive commercialisation award
Enterprise Irelands Industrial
Technologies Annual Conference took place on Thursday
27th of November at the Charlton Hotel in Dublin. Dr Jimmy
Devins TD, Minister for Science and Technology presented Glantreo's
Dr John Hanrahan with an Industrial Technologies Commercialization
Award for his work on development, commercialization and licensing
of the project 'Mesoporous Silica Spheres for Ultra High Performance
Liquid Chromatrography'. This ground breaking technology was
recently licensed to Glantreo Ltd by University COllege Cork
(UCC).
Click here to read more ... |
|
Glantreo & Queens University Belfast
(QUB) sign partnership deal
Glantreo and QUB were recently awarded a FUSION partnership
grant, worth in excess of €100,000, via the cross border
Intertrade Ireland Fusion Initiative. Glantreo’s academic
partner in Northern Ireland is Dr Paul Nancarrow of the Chemical
Engineering Department at Queens University Belfast. Speaking
at a recent trip to Cork Dr Nancarrow was very excited at
the prospect of working with Glantreo. The partnership will
ring fence certain technologies being developed at the Chemical
Engineering Department at QUB.
Click here to read more ... |
|
Convergent Technologies - The synthesis
& characterisation of drug-loaded Hydroxyapatite (HA)
Technology convergence is already a reality in communications,
where it has generated new industry sectors. Increasing emphasis
on translational research in biomedicine, together with the
cross-fertilization of such fields as biotech, nanotech and
information technology, now promise similar interdisciplinary,
convergent solutions for disease prevention, screening, diagnosis,
therapy, monitoring and management.
Click here to read more ... |
Summer 2008
|
Foreign Bodies in GMP Environments
Despite the best efforts of manufacturers to produce to the highest standards, there are a number of ways in which pharmaceuticals may become contaminated by foreign bodies. Such contamination may at best be unwelcome, or at worst potentially life threatening for users of pharmaceutical products such as injectables. From a production point of view, the discovery of a contaminant may render the entire batch unusable, resulting in wasted production time and raw materials.
Click here to read more ... |
|
QC Anaysis on the Manufacturing Floor - Is HPLC ready for PAT?
If process analytic technology (PAT) is not at the tip of your tongue, it should be. This FDA-inspired initiative for real-time, in- process analytics, has been slowly gaining traction thanks to steadfast efforts by instrument vendors and best-in-class biomanufacturers. HPLC will be part of PAT moving forward.
Click here to read more ... |
|
Glantreo & UCC Sign Licensing Deal.
Glantreo Ltd and University College Cork (UCC) today announced the signing of a collaboration agreement, under which Glantreo will license UCC's sub2sila silica manufacturing technology. The sub2sila technology is a unique processing technology that allows the production of a highly monodispersed sub 2 micron silica porous silica particles. The particles have applications in the High performance Liquid Chromatography (HPLC) arena and also in the next generation of HPLC termed Ultra High Performance Liquid Chromatography (UPLC).
Click here to read more ... |
|
Copyright © 2004 - 2008 Glantreo Ltd. All rights
reserved.
|
|
Home